Biotechnology

André is a Co-Founder, Partner, and Chief Investment Officer of HighVista Strategies. He was previously the George Gund Professor of Finance and Banking at the Harvard Business School where he served in senior roles including Senior Associate Dean and Chair of the Finance Faculty. André’s research and teaching were in investment management and the capital markets, for which he won numerous awards. André is a Board Member of The Vanguard Group and RIT Capital Partners and has served on a number of investment committees of not-for-profit institutions including the Mass General Brigham. He received a BSc (Hons) from the University of Witwatersrand, Johannesburg, and an MS and PhD from Stanford University.

Niels is a Partner at HighVista Strategies and focuses on the firm’s public market investments. Prior to joining HighVista in 2018, Niels worked for over ten years in public markets investing at both Highfields Capital and Citadel Investment Group. Niels is a Trustee of Mount Auburn Cemetery where he serves as Chairman of the Investment Committee. Niels received a BS cum laude from Duke University and an MBA from The Wharton School at the University of Pennsylvania, where he was a Joseph Wharton Fellow and a Palmer Scholar.

Adam is a Partner at HighVista Strategies and focuses on equity related investments, including public and private. Prior to joining HighVista in 2016, Adam focused on Public Markets and Absolute Return at Harvard Management Company. In addition, he has worked at Amici Capital, Allston Development Group, and Charles River Associates. Adam received a BA magna cum laude from Middlebury College, an MBA from Harvard Business School, and is a CFA charterholder.

Kathleen is a Vice President on the Public Markets investment team and focuses on the firm’s biotechnology investments. Prior to joining HighVista in 2024, Kathleen worked in equity research at Leerink Partners primarily covering oncology equities, and before that in business development at BridgeBio. Kathleen received a BS in Chemical Engineering from MIT as well as an MS in Biology and PhD in Biochemistry from Harvard University as a Theodore H. Ashford Graduate Fellow.

Maggie is a Senior Associate at HighVista Strategies and focuses on the firm’s public markets investing. Prior to joining HighVista in 2022, Maggie was an associate at Goldman Sachs in the investment banking division. Previously, she worked at Bank of America in the capital markets group. She received a BA from Boston College.

James is an Analyst at HighVista Strategies and focuses on the firm’s public markets investing. He joined HighVista in 2023. He received a BS magna cum laude from The Wharton School of the University of Pennsylvania.